Navigation Links
Westaim terminates reorganization agreement and cancels shareholders' meeting
Date:11/4/2008

CALGARY, Nov. 4 /PRNewswire-FirstCall/ - The Westaim Corporation announced today that its reorganization agreement with several western Canadian construction services companies has been terminated.

Under the terms of the proposed reorganization agreement dated on October 3, 2008, subscription agreements for a private placement of common shares for gross proceeds of $15 million were required to be signed and delivered within 14 days of the mailing of the information circular for Westaim's special meeting of shareholders. Due to the current volatile state of the financial markets and the general state of the investment climate, sufficient subscribers for the private placement could not be found.

As a consequence of terminating the reorganization agreement, Westaim has cancelled the shareholders' meeting called for November 21, 2008.

"Westaim will continue its review of strategic alternatives in light of this development," said Drew Fitch, President & CEO, The Westaim Corporation. "The board of directors will examine all possible options for the longer-term structure of the company moving forward and remain committed to realizing maximum value for shareholders."

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Westaim to deregister its common stock in the United States
2. Westaim announces sale of iFire Technology Ltd. assets
3. Westaim announces 2008 second quarter results
4. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
5. Westaim announces 2008 first quarter results
6. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
7. Westaim announces 2007 year-end results
8. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
9. Westaim reduces ABCP exposure
10. Westaim announces 2007 third quarter results
11. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... 12, 2017 , ... On Saturday, October 21, the Health & Wellness Center ... to raise money for the American Heart Association Heart Walk. Teams of up to ... together to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, ... complete response letter from the U.S. Food and Drug ... approval of sirukumab for the treatment of moderately to ... indicates additional clinical data are needed to further evaluate ... to severely active RA. ...
Breaking Medicine Technology: